| TAP |
Report |
Underlying EPS |
MISS |
pred ~$1.62 vs. cons $1.77 |
MEDIUM |
| TAP |
Report |
Net sales |
IN-LINE |
pred ~$3.18B vs. cons $3.20B |
MEDIUM |
| TAP |
Report |
U.S. financial volume |
MISS |
pred ~-9.4% vs. cons -7.5% |
HIGH |
| TAP |
Guide |
FY26 underlying pretax income |
LOWER |
guide ~$1.17B vs. cons $1.21B (FY26) |
MEDIUM |
| TAP |
Guide |
FY26 underlying EPS |
LOWER |
guide ~$5.38 vs. cons $5.59 (FY26) |
MEDIUM |
| TAP |
Guide |
FY26 underlying free cash flow |
LOWER |
guide ~$1.05B vs. cons $1.10B (FY26) |
MEDIUM |
| TAP |
Return |
Day-1 residual (stock − beta × S&P 500) |
-5.5% |
— |
MEDIUM |
| TAP |
Return |
5-day cumulative residual |
-7.5% (FOLLOW-THROUGH) |
The anticipated EPS/volume miss is likely compounded by a FY26 pretax-income guide of ~$1.17B versus ~$1.21B consensus and FCF of ~$1.05B versus ~$1.10B, pulling down out-period estimates rather than leaving the quarter as a contained 2Q cost-phasing issue. |
MEDIUM |